TALEN based HPV-E7 editing triggers necrotic cell death in cervical cancer cells-Reference-Cited by-同舟云学术

TALEN based HPV-E7 editing triggers necrotic cell death in cervical cancer cells

Published:2017-07-14 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Shankar Sumitra,Prasad Deepti,Sanawar Rahul,Das Ani V.,Pillai M. Radhakrishna

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-05696-0.pdf

Reference42 articles.

1. Molano, M. et al. Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology: a population-based, 5-year follow-up study. American Journal of Epidemiology 158, 486–494 (2003).

2. Bruni, L. et al. ICO Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in the World. Summary Report 2016-02-25. [Data Accessed] (2016).

3. Alvarez-Salas, L. M., Cullinan, A. E., Siwkowski, A., Hampel, A. & DiPaolo, J. A. Inhibition of HPV-16 E6/E7 immortalization of normal keratinocytes by hairpin ribozymes. Proceedings of the National Academy of Sciences of the United States of America 95, 1189–1194 (1998).

4. Butz, K. et al. siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells. Oncogene 22, 5938–5945, doi: 10.1038/sj.onc.1206894 (2003).

5. Horner, S. M. & DiMaio, D. The DNA binding domain of a papillomavirus E2 protein programs a chimeric nuclease to cleave integrated human papillomavirus DNA in HeLa cervical carcinoma cells. Journal of Virology 81, 6254–6264, doi: 10.1128/JVI.00232-07 (2007).

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genome editing and its role in vaccine, diagnosis, and therapeutic advancement;International Journal of Biological Macromolecules;2024-06

2. Molecular prospects of transcription activator-like effector nucleases (TALENs) in cancer management: Challenges and adaptations;Biomarkers in Cancer Detection and Monitoring of Therapeutics;2024

3. Genome Editing: Current Approaches and the Road Ahead in Cancer Research and Therapeutics;Interdisciplinary Cancer Research;2024

4. Genome editing mRNA nanotherapies inhibit cervical cancer progression and regulate the immunosuppressive microenvironment for adoptive T-cell therapy;Journal of Controlled Release;2023-08

5. HPV18 E6 inhibits α‐ketoglutarate‐induced pyroptosis of esophageal squamous cell carcinoma cells via the P53/MDH1/ROS/GSDMC pathway;FEBS Open Bio;2023-07-08